AWAlice Williamson

Alice Williamson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alice Williamson has a total of 333 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk

    by Maik Pietzner, Alice Williamson, Karen A. Hunt, Mine Koprulu, Leonhard Kohleick, Kamil Demircan, David A. van Heel, Sarah Finer, Julia Carrasco Zanini, Claudia Langenberg

    Understanding genetic variation associated with differences in plasma protein levels can elucidate human disease mechanisms. Here we demonstrate how untargeted nanoparticle-enriched mass spectrometry (MS)-based plasma proteomics delivers quantitatively and qualitatively different insights compared to two affinity-based assays in a sample of ~1,400 British South Asian individuals. We identify >1,200 significant locus–protein associations ( P < 8.7 × 10 −12 ; n = 895 cis -protein quantitative trait loci (pQTLs)), more than half of which have not been reported previously. Cross-platform comparison demonstrated that multiple platforms are required to capture the full spectrum of pQTLs of blood proteins. We combine proteogenomic results with evidence from multiple biological domains to suggest a potential role of 21 proteins in the pathology of 44 diseases, including a previously uncharacterized role of immunoglobulin λ variable 3-21 in the development of Graves’ disease. Our results demonstrate the potential of MS-based blood proteomics in non-European ancestries for pQTL discovery and the need to consolidate proteogenomic evidence to confidently assign proteins to disease pathology.


  • Open Access

    Tissue origins of the plasma proteomic response to glucose ingestion in humans

    by Burulça Uluvar, Alice Williamson, Kristoffer J. Kolnes, Per Bendix Jeppesen, Anders J. Kolnes, Mine Koprulu, Martijn Zoodsma, Carl Beuchel, Yanki Bambal, Mar Reines, et al.

    Aims/hypothesis: Circulating proteins act as important hormonal signals of nutrient intake. We aimed to systematically characterise the time-resolved proteomic response to glucose ingestion in humans, and to assess its robustness following prolonged complete caloric restriction. Methods: We conducted oral glucose tolerance tests (OGTTs) in 11 healthy volunteers before and after 7 days of complete caloric restriction and measured the response of >2900 targets through high-resolution plasma protein profiling. Results: We identified a signature of 44 proteins that changed significantly following glucose ingestion, which was reproducible after 7 days without food, and was strongly (20-fold) enriched for ‘stomach-specific’ proteins. We report that annexin A10 (ANXA10) shows the most significant post-glucose change observed, similar to the trajectories of secreted hormones. We present observational human evidence from multiple sources suggesting that ANXA10 is secreted upon sensing an increase in gastric pH, with the stomach as the major contributing tissue. Despite a profound metabolic shift after 7 days of complete caloric restriction, characterised by delayed insulin secretion and postprandial hyperglycaemia, only four proteins showed robust evidence for a differential trajectory during both OGTTs. This included plasma levels of tryptophanyl-tRNA synthetase 1 (WARS), for which we found a genetic association with glucose homeostasis and coronary artery disease. Conclusions/interpretation: Our exploratory study identifies the proteomic response to glucose ingestion and demonstrates its reproducibility despite major shifts in glucose homeostasis. We characterise the gastrointestinal origin of these changes, and hypothesise a hitherto under-recognised role for sensing of changes in gastric pH on the plasma proteome.

  • Open Access

    Proteogenomic origins of disease in British South Asians

    by Alice Williamson, Julia Carrasco Zanini, Martijn Zoodsma, Mine Koprulu, Arslan Zaidi, Karen A Hunt, Emma Sol Taylor-Brill, Leonhard Kohleick, Genes & Health Industry Consortium, Genes & Health Research Team, et al.

    Proteogenomic studies have transformed the way we derive novel insights into human biology and pathophysiology but are currently limited by their proteomic coverage and ancestral representation. Here, we integrate rare and common genetic variation with measurements of >11,000 plasma proteins on two affinity-based platforms (>6,000 targets not previously covered) in 1,535 individuals of British Bangladeshi and Pakistani ancestry of the Genes & Health cohort. We report 3,826 high-confidence common (minor allele frequency (MAF)>1.0%) protein quantitative trait loci (pQTLs), over half of which are novel and including >200 pQTLs with greater MAF in South Asians. Systematic analyses of rare (MAFMT-RNR1 , associated with lower myelin protein zero (MPZ), identifying a potential novel mechanistic link for MT-RNR1 ’s poorly understood role in hearing loss. We create the first proteogenomic disease network in individuals of South Asian ancestry based on 384 cis-pQTL with a shared genetic disease or risk factor signal, including conditions substantially more common in South Asians, such as metabolic diseases or pregnancy-related conditions, providing insights into the underlying mechanisms. In summary, our study demonstrates the value and scientific efficiency of proteomic studies in genetically informative and understudied populations for identifying novel causes of globally relevant diseases.


  • Glycerol-driven TNAP activation in thermogenesis and mineralization

    by Mohammed Faiz Hussain, Shreya S. Krishnan, Brittany L. Carroll, Bozena Samborska, Aisha Mousa, Alice Williamson, Maria Delgado-Martin, Bindu Y. Srinivasu, Jakub Bunk, Janane F. Rahbani, et al.

    Tissue-nonspecific alkaline phosphatase (TNAP) promotes skeletal mineralization by hydrolysing pyrophosphate1 and has been linked to uncoupling protein 1 (UCP1)-independent adipocyte thermogenesis through the futile creatine cycle through phosphocreatine hydrolysis2,3. Despite TNAP’s broad physiological roles, endogenous regulators of its activity have not been defined. Furthermore, the activation mechanism of UCP1-independent thermogenesis has remained unresolved. Here we identify glycerol as an allosteric activator of TNAP. Glycerol binds to a surface pocket distal to the active site, which we term the glycerol pocket, to enhance TNAP activity. Using biophysical, structural, bioenergetic and physiological approaches, we show that the glycerol pocket is required for TNAP-driven thermogenesis. Through this mechanism, TNAP activates the futile creatine cycle, acting as a physiological complement to UCP1. The glycerol pocket is likewise required for optimal osteoblast-regulated mineralization. Human missense variants in this site reduce TNAP-dependent mineralization in vitro and are associated with lower alkaline phosphatase activity and bone mineral density, providing genetic evidence that its disruption impairs skeletal physiology.


  • Open Access

    Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk

    by Stefanie Zorn, Rebecca Bounds, Alice Williamson, Katherine Lawler, Ruth Hanssen, Julia Keogh, Elana Henning, Miriam Smith, Barbara A. Fielding, A. Margot Umpleby, et al.

    Obesity causes dyslipidemia and is a major risk factor for cardiovascular disease. However, the mechanisms coupling weight gain and lipid metabolism are poorly understood. Brain melanocortin 4 receptors (MC4Rs) regulate body weight and lipid metabolism in mice, but the relevance of these findings to humans is unclear. Here we investigated lipid levels in men and women with obesity due to MC4R deficiency. Among 7,719 people from the Genetics of Obesity Study cohort, we identified 316 probands and 144 adult family members with loss-of-function (LoF) MC4R mutations. Adults with MC4R deficiency had lower levels of total and low-density lipoprotein (LDL)-cholesterol and triglycerides than 336,728 controls from the UK Biobank, after adjusting for adiposity. Carriers of LoF MC4R variants within the UK Biobank had lower lipid levels and a lower risk of cardiovascular disease, after accounting for body weight, compared to noncarriers. After a high-fat meal, the postprandial rise in triglyceride-rich lipoproteins and metabolomic markers of fatty acid oxidation were reduced in people with MC4R deficiency compared to controls, changes that favor triglyceride storage in adipose tissue. We concluded that central MC4Rs regulate lipid metabolism and cardiovascular disease risk in humans, highlighting potential therapeutic approaches for cardiovascular risk reduction.


  • Open Access

    A genetic map of human metabolism across the allele frequency spectrum

    by Martijn Zoodsma, Carl Beuchel, Summaira Yasmeen, Leonhard Kohleick, Aakash Nepal, Mine Koprulu, Florian Kronenberg, Manuel Mayr, Alice Williamson, Maik Pietzner, et al.

    Genetic studies of human metabolism have been limited in scale and allelic breadth. Here we provide a data-driven map of the genetic regulation of circulating small molecules and lipoprotein characteristics (249 traits) measured using proton nuclear magnetic resonance spectroscopy across the allele frequency spectrum in ~450,000 individuals. Trans-ancestral meta-analyses identify 29,824 locus–metabolite associations mapping to 753 regions with effects largely consistent between men and women and large ancestral groups represented in UK Biobank. We observe and classify extreme genetic pleiotropy, identify regulators of lipid metabolism, and assign effector genes at >100 loci through rare-to-common allelic series. We propose roles for genes less established in metabolic control (for example, SIDT2), genes characterized by phenotypic heterogeneity (for example, APOA1) and genes with specific disease relevance (for example, VEGFA). Our study demonstrates the value of broad, large-scale metabolomic phenotyping to identify and characterize regulators of human metabolism.


  • Open Access

    An ancestry-enriched HNF4A variant and GP2 reveal distinct mechanisms of type 2 diabetes in exome-wide study of 13,674 cases and 41,024 controls

    by Sam Hodgson, Vi Bui, Siqi Hu, Cyrielle Maroteau, Margherita Bigossi, Alicia Huerta-Chagoya, Trang Nguyen, Adem Y. Dawed, Ryan Koesterer, Maheak Vora, et al.

    / Introductory Paragraph: Type 2 diabetes (T2D) is a common and complex metabolic condition with significant heterogeneity within and across ancestries 1–4 . Compared with individuals of European ancestry (EUR), people of south Asian ancestry (SAS) have two to four-fold higher risk of T2D, develop the disease at younger ages and lower body mass index (BMI), and experience more rapid progression to complications 5–10 . Understanding the genetic basis of this is hindered by low representation of south Asians in genetic studies. Here, we perform an exome-wide association study of T2D in 13,674 cases and 41,024 controls from the Genes & Health study of British Pakistani and Bangladeshi individuals. We identify a novel rare variant in HNF4A – a canonical monogenic diabetes / MODY gene, in which missense variants would be expected to increase T2D risk. Surprisingly, HNF4A Pro437Ser is associated with a halved risk of T2D and reduced risk of diabetes-related complications but increased non-HDL cholesterol. We additionally characterise a T2D risk-increasing variant which is common only in South and East Asian ancestral groups ( GP2 Val429Met), which is associated with lower BMI and phenotypic and genetic markers of insulin deficiency. We validate our findings through replication in independent multi-ancestry cohorts, in vitro functional assays, and integration of proteogenomic analysis. These findings highlight how the study of under-represented populations can identify biological mechanisms associated with disease phenotypes enriched in those populations.

  • Open Access

    A genetic map of human metabolism across the allele frequency spectrum

    by Martijn Zoodsma, Carl Beuchel, Summaira Yasmeen, Leonhard Kohleick, Aakash Nepal, Mine Koprulu, Florian Kronenberg, Manuel Mayr, Alice Williamson, Maik Pietzner, et al.

    Genetic studies of human metabolism identified unknown disease processes and novel metabolic regulators, but have been limited in scale and allelic breadth. Here, we provide a data-driven map of the genetic regulation of circulating small molecules and lipoprotein characteristics (249 metabolic traits) measured using protein nuclear magnetic resonance spectroscopy (1H-NMR) across the allele frequency spectrum in ∼450.000 individuals. In trans-ancestry analyses, we identify 29,824 locus–metabolite associations mapping to 753 regions with effects largely consistent between men and women and major ancestral groups represented in UK Biobank. We develop a framework for classifying the observed extreme genetic pleiotropy, enabling identification of upstream ‘master’ regulators of lipid metabolism (’proportional pleiotropy’), such as ANGPTL3. We establish rare-to-common allelic series by integrating machine-learning guided effector gene assignments with rare exonic variant analyses providing high confidence gene assignments at >100 loci, including less established regulators of lipid metabolism like SIDT2. At 17 such loci we observed phenotypic heterogeneity among variants mapping to the same gene indicating differential metabolic roles of the altered gene product. We identify VEGFA as a potential modulator of HDL-mediated risk for coronary artery disease. Our results demonstrate how rare-to-common genetic variation combined with deep molecular profiling can identify unknown and inform on poorly understood regulators of human metabolism to guide prevention and treatment of diseases.


  • Open Access

    Genetic basis of early onset and progression of type 2 diabetes in South Asians

    by Sam Hodgson, Alice Williamson, Margherita Bigossi, Daniel Stow, Benjamin M. Jacobs, Miriam Samuel, Joseph Gafton, Julia Zöllner, Marie Spreckley, Claudia Langenberg, et al.

    South Asians develop type 2 diabetes (T2D) early in life and often with normal body mass index (BMI). However, reasons for this are poorly understood because genetic research is largely focused on European ancestry groups. We used recently derived multi-ancestry partitioned polygenic scores (pPSs) to elucidate underlying etiological pathways British Pakistani and British Bangladeshi individuals with T2D (n = 11,678) and gestational diabetes mellitus (GDM) (n = 1,965) in the Genes & Health study (n = 50,556). Beta cell 2 (insulin deficiency) and Lipodystrophy 1 (unfavorable fat distribution) pPSs were most strongly associated with T2D, GDM and younger age at T2D diagnosis. Individuals at high genetic risk of both insulin deficiency and lipodystrophy were diagnosed with T2D 8.2 years earlier with BMI 3 kg m− 2 lower compared to those at low genetic risk. The insulin deficiency pPS was associated with poorer HbA1c response to SGLT2 inhibitors. Insulin deficiency and lipodystrophy pPSs were associated with faster progression to insulin dependence and microvascular complications. South Asians had a greater genetic burden from both of these pPSs than white Europeans in the UK Biobank. In conclusion, genetic predisposition to insulin deficiency and lipodystrophy in British Pakistani and British Bangladeshi individuals is associated with earlier onset of T2D, faster progression to complications, insulin dependence and poorer response to medication.


  • Open Access

    Testing for a causal role of thyroid hormone measurements within the normal range on human metabolism and diseases: a systematic Mendelian randomization

    by Heba Alwan, Jian'AN Luan, Alice Williamson, Julia Carrasco-Zanini, Isobel D. Stewart, Nicholas J. Wareham, Claudia Langenberg, Maik Pietzner